跳至主要内容
临床试验/EUCTR2006-003180-31-NL
EUCTR2006-003180-31-NL进行中(未招募)不适用

Comparative efficacy and safety of two asparaginase preparations in children with previously untreated acute lymphoblastic leukaemia - Comparative efficacy and safety of two asparaginase preparations in children with de novo A

medac GmbH0 个研究点开始时间: 2008年3月18日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
medac GmbH

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Previously untreated T-lineage or precursor B-lineage ALL
  • - Patients must have morphological proof of ALL and diagnosis must be
  • made from bone marrow morphology with ? 25% blasts
  • - Age 1 year to 18 years
  • - Written informed consent
  • - Treatment according to DCOG ALL 10 protocol
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Mature B-lineage ALL
  • - Patients with secondary ALL
  • - Known allergy to any ASNase preparation
  • - General health status according to Karnofsky / Lansky score < 40%
  • - Pre-existing known coagulopathy (e.g. haemophilia)
  • - Pre-existing pancreatitis
  • - Liver insufficiency (Bilirubin > 50 µmol/L; SGOT/SGPT > 10 x ULN)
  • - Other current malignancies
  • - Pregnancy (planned or existent), breast feeding

研究者

发起方
medac GmbH

相似试验

Comparative efficacy and safety of two asparaginase... | 临床试验